Human Growth Hormone Market Report (2023 to 2031) – Pfizer, Inc., Novo Nordisk

Newark, New Castle, USA, June 18, 2023 (GLOBE NEWSWIRE) — Growth Plus Reports estimated the size of the global market for human growth hormone in 2022 to be worth US$ 4.4 billion, and it is expected that it will increase at a revenue CAGR of 8.4% to reach US$ 9.1 billion by 2031.

The global market for human growth hormone was analyzed and is expected to rise significantly in terms of revenue share during the forecast period. Children’s growth and development are significantly aided by human growth hormone (HGH). Additionally, it controls both children’s and adults’ metabolism, muscle and bone growth, and body composition.

Key Takeaways: 

• The rise of growth hormone deficiency is driving the market revenue share.

• The growing demand for anti-aging treatments has led to a surge in market demand.

• The recombinant DNA technology has significantly improved the efficiency and scalability of HGH production.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/human-growth-hormone-market/8847

                                  Human Growth Hormone Market Scope

Recent Development in the Human Growth Hormone Market: 

• In February 2022, The European Commission granted marketing approval to Pfizer Inc. and OPKO Health Inc. for the once-weekly injection of next-generation long-acting recombinant human growth hormone NGENLATM (somatrogon), which is used to treat children and adolescents from the age of 3 who have growth disturbances caused by insufficient growth hormone secretion.

Story continues

Competitive Landscape

A list of the prominent players operating in the global market for human growth hormones includes:

• Merck KGaA

• Novo Nordisk Inc.

• Pfizer, Inc

• AnkeBio Co. Ltd

• Eli Lilly and Company

Market Drivers and Restraints: 

The global human growth hormone market revenue is driven by the Increasing prevalence of growth hormone deficiency, growing demand for anti-aging treatments, technological advancements, and availability of government funding and favorable policies for research and development.

However, due to high expenses and the availability of alternative treatment options, the human growth hormone market revenue growth is expected to be restrained.

Market Segmentation: 

Segmentation By Indication

Based on the products, the growth hormone deficiency segment dominates the global human growth hormone market with the largest revenue share. This large revenue share is attributed to it as it is the primary and most prevalent indication for human growth hormone treatment, and there is a constant demand for growth hormone supply since many GHD patients require long-term human growth hormone therapy.

Segmentation By Route of Administration

Based on the route of administration, the parenteral segment dominates the global human growth hormone market with the largest revenue share. Growth hormones can be administered by the simple and practical intramuscular (IM) parenteral route, which is effective for administering human growth hormones and may improve patient compliance. This helps the segment’s revenue growth to rise rapidly.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/human-growth-hormone-market/8847

Segmentation By Distribution Channel

Based on distribution channels, the hospital pharmacies segment accounts for the highest revenue share in the global human growth hormone market as for people with serious or persistent medical conditions, such as growth hormone deficiency, they can offer long-term human growth hormone therapy.

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global human growth hormone market. This large revenue share is due to the region having an advanced healthcare system with a high level of diagnosis and comprehension of these issues, which has an impact on the market’s strong demand for products containing human growth hormones.

Report Coverage 

Growth Plus Reports analyzed the global market for human growth hormones in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

1. INTRODUCTION

   1. Market Ecosystem

   2. Timeline Under Consideration

      1. Historical Years – 2021

      2. Base Year – 2022

      3. Forecast Years – 2023 to 2031

   3. Currency Used in the Report

2. RESEARCH…